BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

   

CATALYST
FOR QUALITY

Product/Service Information


URINE CSF
PROTEIN LIQUID
REAGENTS, CALIBRATOR & CONTROLS

2-REAGENT SYSTEM
FULLY AUTOMATED

LINEARITY TO 200 MG/DL

PRECISION

Urine CSF Precision
Mean SD CV
Mg/dl Mg/dl %
12.5 0 0
25 0.789 3.13
50 1.252 2.44
100 1.99 1.85

 

 

URINE CSF PROTEIN (MICROPROTEIN)

Catachem introduces the VetSpec™ Urine CSF Protein (Microprotein) In-Vitro Diagnostic Chemistry reagent test kit.  Catachem is pleased to announce the  introduction of our new reagent system with calibrator and controls.

Several methods have been described for the quantitative determination of Total  Protein in urine and cerebrospinal fluid (CSF). Procedures utilizing dye-binding  suffer from interferences making the protein assay inaccurate. Other procedures are time consuming, tedious and unsuitable for automated analysis. Catachem Protein procedure for urine and CSF is based on the work of Wata I., Nishikaze O., subsequently modified by Richard W. Luxton et al. In this procedure benzathonium chloride reacts with protein to produce a homogeneous and stable turbidity. The  procedure shows the same reactivity either with albumin or g-globulin. Interference from short peptides is not observed and interference from magnesium is prevented by the presence of EDTA in the Working Reagent. 

Interfering Substances

The following substances have no significant effect on the accuracy of this Urine CSF Protein procedure:

Ascorbic acid  Cefazolin  Sodium Magnesium
Calcium  Glucose Phosphorus
Creatinine Gentamicin Sulfate Sodium Citrate
Chlorpromazine  L-Dopa Uric Acid

Method Performance Characteristics

Sensitivity: Using a pathlength of 1 cm, a Δ-absorbance of 0.0016-0.0024 per mg/dl should be obtained.

Linearity: In this procedure there is no significant nonlinearity over the range of     0-200 mg/dL (0-2000 mg/L)

Precision: Precision data was obtained using three levels of protein based controls and following the NCCLS EP5-T2 procedure. The following results were observed. 

Accuracy

Correlation studies were carried out between this automated Urine CSF Protein method (Y) and a reference automated Urine CSF Protein procedure based on the benzathonium chloride reactions (X). Samples were assayed and the results         compared by the least square regression. The following statistics were observed: 

 N    =   26
                Range  =  12-200 mg/dL
   Mean Y  =  81.35
  Mean X   =  78.24
                       Y   =  0.995X – 1.201
         r  = 1.000    
    Sy.x  =  2.02
 

 


CATACHEM, INC.

 

955 Connecticut  Avenue
Suite 4106
Bridgeport , CT 06607
Phone: 203-335-9277
Fax: 203-335-9977

E-mail: catachem@catacheminc.com

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.